Janux Therapeutics (JANX) Stock Price
$36.01 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
7 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Janux Therapeutics, AI stock picks, stock alerts and much more.
JANX AI Stock Analysis
AI stock analysis for JANX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Janux Therapeutics (JANX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Janux Therapeutics (JANX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Janux Therapeutics (JANX), currently trading at $36.01, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About JANX
-
Janux Therapeutics, Inc.
-
Symbol
JANX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
JANX Alternative Data
Web Traffic
Janux Therapeutics receives an estimated 8329 monthly visitors to januxrx.com.
-
Web Traffic
8329
-
Change from Previous Month
44.1%
-
3 Month Change
16.7%
-
YoY Change
16.7%
News Mentions
Janux Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Janux Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Janux Therapeutics has 102 Twitter Followers on its main Twitter (also known as X) account, which is up by 3% over the last month.
-
Twitter Followers
102
-
Daily Change
0%
-
1 Month Change
3%
-
3 Month Change
0%
LinkedIn Followers
7,583 are following Janux Therapeutics on LinkedIn, up by 5.7% over the last month.
-
LinkedIn Followers
7583
-
Daily Change
0.3%
-
1 Month Change
5.7%
-
3 Month Change
16.3%
Job Postings
Janux Therapeutics currenly has an estimated 14 open job postings, up by 27.3% over the last month.
-
Job Postings
14
-
Daily Change
0%
-
1 Month Change
27.3%
-
3 Month Change
75%
LinkedIn Employees
According to LinkedIn, Janux Therapeutics has 83 employees, up by 5.1% over the last month.
-
LinkedIn Employees
83
-
Daily Change
0%
-
1 Month Change
5.1%
-
3 Month Change
6.4%
Business Outlook
-
Business Outlook
63
-
Change from Previous Month
37%
-
3 Month Change
0%
-
YoY Change
0%
JANX Financials
JANX Key Metrics
-
Total Revenue
$439K
-
Net Income
-$28.1M
-
Earnings per Share
-$0.51
-
Free cash flow
-$2.3M
-
EBITDA
-$35.8M
-
EBITDA Ratio
-81.6446
-
Total Assets
$695M
JANX 2-year Revenue & Income
JANX 2-year Free Cash Flow
JANX Technicals
JANX SMA
JANX RSI
FAQ
What's the current price of Janux Therapeutics (JANX) Stock?
The price of an Janux Therapeutics (JANX) share is $36.01.
What's the market cap of Janux Therapeutics?
The current market cap of Janux Therapeutics is 2.1B.
Should I buy or sell JANX?
Janux Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Janux Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Janux Therapeutics a good investment?
The current analysis of Janux Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Janux Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Janux Therapeutics (JANX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Janux Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Janux Therapeutics (JANX) that investors often compare it to?
Janux Therapeutics (JANX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Janux Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Janux Therapeutics' stock price to be around $36.78 in 2026. Starting from the current price of $36.01, this represents a 2.1% change in price, indicating a neutral outlook for the stock.
How to buy Janux Therapeutics (JANX) Stock?
Janux Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Janux Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.